HtrA Serine Peptidase 2 (HTRA2) (Middle Region) Peptide
HTRA2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5511274
Quick Overview for HtrA Serine Peptidase 2 (HTRA2) (Middle Region) Peptide (ABIN5511274)
Target
HTRA2
(HtrA Serine Peptidase 2 (HTRA2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- VTPDTRTREA SENSGTRSRA WLAVALGAGG AVLLLLWGGG RGPPAVLAAV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- HTRA2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HTRA2 (HtrA Serine Peptidase 2 (HTRA2))
-
Background
-
This gene encodes a serine protease. The protein has been localized in the endoplasmic reticulum and interacts with an alternatively spliced form of mitogen-activated protein kinase 14. The protein has also been localized to the mitochondria with release to the cytosol following apoptotic stimulus. The protein is thought to induce apoptosis by binding the apoptosis inhibitory protein baculoviral IAP repeat-containing 4. Nuclear localization of this protein has also been observed. Alternate splicing of this gene results in two transcript variants encoding different isoforms. Additional transcript variants have been described, but their full-length sequences have not been determined.
Alias Symbols: OMI, PARK13, PRSS25
Protein Size: 377 -
Gene ID
- 27429
Target
-
You are here:
